Tourmaline Bio to Present at the Jefferies Global Healthcare ConferenceTourmaline Bio to Present at the Jefferies Global Healthcare Conference

Tourmaline Bio to Present at the Jefferies Global Healthcare Conference

1 year ago

NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative…

Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 ConferencePneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference

Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference

1 year ago

 Neumifil delivers statistically significant reductions in influenza symptomatic infection rate, symptom severity and viral loadStrategy to advance clinical development of…

Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus SymposiumAmphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium

Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium

1 year ago

PRESS RELEASE Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium…

Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’

Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’

1 year ago

Solei’s New Cannabis-Infused Topical Solution is Made for Active Lifestyle EnthusiastsTORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- May 23, 2024…

TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical TestingTFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing

TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing

1 year ago

The Leidos team’s Next-Generation Medical Countermeasures (MCMs) Successfully Formulated with Company’s Proprietary Thin Film Freezing Technology MCM Candidates Demonstrated Chemical…

Script Runner launches Canada’s first AI-powered drone delivery service, revolutionizing healthcare access for remote communitiesScript Runner launches Canada’s first AI-powered drone delivery service, revolutionizing healthcare access for remote communities

Script Runner launches Canada’s first AI-powered drone delivery service, revolutionizing healthcare access for remote communities

1 year ago

Thunder Bay test flight bridges healthcare gap; Canadian company prioritizes patient care with last-mile solutions THUNDER BAY, Ontario, May 23,…

OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and PlatformOneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform

OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform

1 year ago

MINNEAPOLIS, May 23, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade…

ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2024 Q1 FINANCIAL RESULTSARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2024 Q1 FINANCIAL RESULTS

ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2024 Q1 FINANCIAL RESULTS

1 year ago

Greenville, South Carolina, May 23, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based…

atai Life Sciences Strengthens Board with Appointment of Two New Independent Directorsatai Life Sciences Strengthens Board with Appointment of Two New Independent Directors

atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors

1 year ago

NEW YORK and BERLIN, May 23, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical…